HeartBeam commences pilot study of new 12-lead ECG patch

HeartBeam has commenced a pilot study to evaluate its on-demand 12-lead ECG patch in patients with suspected coronary artery disease. The study will enrol around 50 high-risk coronary artery disease patients whose resting ECGs show no signs of ischemia. The patch is designed to extend cardiac monitoring beyond hospital settings. Credit: Ws Studio1985 / Shutterstock.com. HeartBeam has initiated a pilot study to evaluate its on-demand 12-lead electrocardiogram (ECG) patch in patients with suspected coronary artery disease. The study is taking place at two hospitals in Belgrade, Serbia, and marks a key stage in the development of the HeartBeam patch, which…

Source: Medical Device Network